sorafenib has been researched along with Leukoencephalopathy Syndrome, Posterior in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duprez, T; Filleul, B; Laruelle, M; Machiels, JP | 1 |
| Bayhan, T; Cetin, M; Gumruk, F; Isgandarova, F; Kuskonmaz, B; Tavil, B; Unal, S | 1 |
| Aksoy, S; Altundag, K; Arslan, C; Dede, DS; Dogan, E | 1 |
4 other study(ies) available for sorafenib and Leukoencephalopathy Syndrome, Posterior
| Article | Year |
|---|---|
Drug-induced posterior reversible encephalopathy syndrome.
Topics: Adrenal Cortex Hormones; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Bevacizumab; Humans; Immunosuppressive Agents; Nasal Decongestants; Posterior Leukoencephalopathy Syndrome; Protein Kinase Inhibitors; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Sorafenib; Vascular Endothelial Growth Factor A; Vasoconstrictor Agents | 2017 |
Posterior Reversible Encephalopathy Syndrome Associated with Sorafenib and Successful Retreatment.
Topics: Aged; Blood Pressure; Brain; Carcinoma, Renal Cell; Female; Humans; Hypertension; Immunosuppressive Agents; Kidney Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Posterior Leukoencephalopathy Syndrome; Sorafenib; Thrombosis; Vascular Endothelial Growth Factor A | 2018 |
Sorafenib-induced Posterior Reversible Encephalopathy Syndrome in a Child With FLT3-ITD-positive Acute Myeloid Leukemia.
Topics: Antineoplastic Agents; Child; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Posterior Leukoencephalopathy Syndrome; Salvage Therapy; Sorafenib | 2016 |
Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Posterior Leukoencephalopathy Syndrome; Prognosis; Pyridines; Sorafenib | 2010 |